Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy

Status:
Recruiting

Trial end date:
2024-06-01

Target enrollment:

Participant gender:

Multicentre Study of nomacopan in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy

Phase 3

AKARI Therapeutics